Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs

Summary

The purpose of this study is to compare the safety and pharmacokinetics of PK101(fixed-dose combination of PK101-001 and PK101-002) with coadministration of the two separate drugs in healthy volunteers.

Timeline

Start

2019-07-12

Primary completion

2019-07-22

Completion

2019-08-05

Publications

• Song JH, Koh H, Moon HY, Jung JG, Hong JH, Sunwoo J. Comparison of a fixed-dose combination of Celecoxib/PG201 [Layla(R)] versus co-administration of individual formulations in healthy participants: A randomized trial. Medicine (Baltimore). 2024 Nov 15;103(46):e40494. doi: 10.1097/MD.0000000000040494.

Drugs

Indications